BGM on Nasdaq

BGM Group Ltd.

Price unavailable

Last updated Oct 16, 2026.

Overview

$37.9MRevenue, fiscal 2025²

-$19.9MNet income, fiscal 2025²

Compare with LFTD PARTNERS INC., Sunshine Biopharma Inc. or Enveric Biosciences, Inc., or pick any stock.

TickerBGM on Nasdaq
IndustryPharmaceutical Preparations
HeadquartersE9
Incorporated inCayman Islands³
Business addressNo. 152 Hongliang East 1St Street, No. 1703, Tianfu New District, Chengdu, 0000³
Filer categoryNon-accelerated filer, Emerging growth company³

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

16.6%Gross margin²

-33.2%Operating margin²

-52.6%Net margin²

51.1%Revenue growth, 2025²

-5.1%Return on equity²

-$3.9MFree cash flow²

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Diversified Pharmaceutical and Allied Products brought in 62% of the revenue BGM Group Ltd. broke down this way in fiscal 2025.

Diversified Pharmaceutical and Allied Products$23.6M²62%down 6% from 2024
Insurance Business$11.0M²29%
AI Solutions$3.4M²9%

Business segments by year

Business segments	2023	2024	2025
Diversified Pharmaceutical and Allied Products	$46.5M	$25.1M	$23.6M
Insurance Business			$11.0M
AI Solutions			$3.4M

Where the money goes

Where each dollar of revenue went, fiscal 2025

Cost of revenueSelling, general and admin

Cost of revenue62¢$31.6M
Research and development1¢$672.7K
Selling, general and admin36¢$18.2M
Income tax1¢$277.8K

Out of $37.9M in revenue.² The company lost money this year.

Financial statements

Revenue⁴⁵⁶⁷⁸²$37.9M in 2025−25% since 2018

Gross profit⁴⁵⁶⁷⁸²$6.3M in 2025−22% since 2018

Operating income⁴⁵⁶⁷⁸²-$12.6M in 2025

Net income⁴⁵⁶⁷⁸²-$19.9M in 2025

Every line of the income statement in the latest annual report, as filed.²

Period ending	2025-09-30	2024-09-30	2023-09-30
NET REVENUE	$37.9M	$25.1M	$46.5M
COST OF REVENUE	$31.6M	$21.0M	$44.7M
GROSS PROFIT	$6.3M	$4.1M	$1.8M
SELLING, GENERAL AND ADMINISTRATIVE	$18.2M	$3.3M	$3.8M
RESEARCH AND DEVELOPMENT EXPENSES	$672.7K	$1.4M	$568.5K
LOSS FROM OPERATIONS	-$12.6M	-$563.8K	-$2.6M
Interest income (expense), net	$83.1K	-$639.5K	$99.2K
Investment loss	-$7.7M	-$819.4K	-$5.5M
Loss on disposal of long term investment		-$101.4K
Share of results of associates	-$427.7K	-$204.6K
Grant income	$132.3K	$206.4K	$192.4K
Other Income (expenses)	$555.0K	-$14.8K	-$61.0K
Total other expense	-$7.4M	-$1.6M	-$5.3M
LOSS BEFORE INCOME TAX PROVISION	-$19.9M	-$2.1M	-$7.9M
INCOME TAX EXPENSE/(BENEFIT)	$277.8K	-$620.0K	$219.2K
NET LOSS	-$20.2M	-$1.5M	-$8.1M
Less: net loss attributable to non-controlling interest	-$274.8K	-$74.3K	-$341.4K
NET LOSS ATTRIBUTABLE TO BGM Group Ltd.	-$19.9M	-$1.4M	-$7.8M
Foreign currency translation adjustment	$3.8M	$1.3M	-$730.9K
COMPREHENSIVE LOSS	-$16.4M	-$258.1K	-$8.9M
Less: comprehensive loss attributable to non - controlling interests	-$330.1K	-$210.2K	-$381.4K
COMPREHENSIVE LOSS ATTRIBUTABLE TO BGM Group Ltd.	-$16.1M	-$47.9K	-$8.5M
Earnings (loss) per common share - basic (in dollar per share)	-$0.18	-$0.20	-$1.08
Earnings (loss) per common share - diluted (in dollar per share)	-$0.18	-$0.20	-$1.08
Weighted average shares - basic (in shares)	113.3M shares	7.2M shares	7.2M shares
Weighted average shares - diluted (in shares)	113.3M shares	7.2M shares	7.2M shares

Total assets⁴⁵⁶⁷⁸²$433.8M in 2025+1130% since 2019

Total liabilities⁴⁵⁶⁷⁸²$41.9M in 2025+232% since 2019

Shareholders’ equity⁴⁵⁶⁷⁸²$390.9M in 2025+2106% since 2018

Cash⁵⁴⁶⁷⁸²$9.8M in 2025+75% since 2018

Every line of the balance sheet in the latest annual report, as filed.²

Period ending	2025-09-30	2024-09-30	2023-09-30
Cash and cash equivalent	$9.8M	$9.8M
Restricted Cash	$870
Accounts receivable, net	$4.3M	$1.5M
Bank acceptance notes receivable	$2.9M	$3.3M
Inventories, net	$20.1M	$5.0M
Prepayment to suppliers, net	$3.6M	$803.9K
Investment in trading securities	$994.9K	$8.3M
Other current assets	$9.9M	$894.5K
TOTAL CURRENT ASSETS	$51.5M	$29.8M
Property and equipment, net	$10.7M	$8.6M
Construction in progress	$4.0M	$5.6M
Intangible assets, net	$4.5M	$4.5M
Goodwill	$350.8M
Long term investment	$11.5M	$3.4M
Operating lease right of use assets	$316.0K
Deferred tax assets	$246.4K	$424.5K
Prepayments for property and equipment		$660.6K
Other long term assets	$117.5K
TOTAL ASSETS	$433.8M	$53.0M
Bank loans	$1.6M
Insurance premium payables	$1.3M
Accounts payable	$6.6M	$4.1M
Contract liabilities	$3.1M	$489.8K
Deferred government grants-current	$80.0K	$78.7K
Taxes payable	$907.3K	$315.3K
Operating lease liabilities, current	$240.9K
Due to related party	$340.6K	$2.9M
Accrued expenses and other payables	$27.4M	$915.0K
TOTAL CURRENT LIABILITIES	$41.6M	$8.8M
Operating lease liabilities, noncurrent	$79.3K
Deferred government grants - noncurrent	$240.2K	$134.4K
TOTAL LIABILITIES	$41.9M	$8.9M
Ordinary Shares, $0.00833335 par value, 5,030,000,000 and 100,000,000 shares authorized, 200,623,358 and 7,226,480 Ordinary Shares, consisting of 180,623,358 and 7,226,480 Class A ordinary shares, par value US$0.00833335 per share, and 20,000,000 Class B ordinary shares, par value US$0.00833335 per share, as of September 30, 2025 and 2024 respectively	$1.7M	$59.6K
Additional paid-in capital	$399.0M	$36.4M
Statutory Reserve	$3.5M	$3.3M
Accumulated (deficit) earnings	-$15.8M	$4.3M
Accumulated other comprehensive profit (loss)	$2.5M	-$1.3M
Total shareholders' equity attributable to BGM Group Ltd.	$390.9M	$42.7M
Noncontrolling interests	$1.0M	$1.3M
TOTAL SHAREHOLDERS' EQUITY	$391.9M	$44.1M	$44.4M
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$433.8M	$53.0M
Ordinary Shares, par value (in dollar per share)	$0.01	$0.01
Ordinary Shares, shares authorized	5.0B shares	100.0M shares
Ordinary Shares, shares issued	200.6M shares	7.2M shares
Ordinary Shares, shares outstanding	200.6M shares	7.2M shares

Cash from operations⁴⁵⁶⁷⁸²-$2.4M in 2025

Capital spending⁴⁵⁶⁷⁸²$1.6M in 2025+40% since 2018

Free cash flow⁴⁵⁶⁷⁸²-$3.9M in 2025

Dividends paid⁴²$1.8M in 2023+144% since 2018

Every line of the cash flow in the latest annual report, as filed.²

Period ending	2025-09-30	2024-09-30	2023-09-30
Net loss	-$20.2M	-$1.5M	-$8.1M
Non-cash operating lease expenses	$60.7K	$60.8K	$26.0K
Depreciation and amortization	$1.5M	$1.2M	$1.1M
Stock based compensation	$10.2M
Credit loss for accounts receivable	$94.1K	$127.6K	$37.9K
Provision (reverse) for other receivables	$238.3K	-$55.4K
Allowance for ATV	$139
Impairment of property and equipment	$194.9K
Inventories provision (reserve)	$452.4K	-$813.6K	$388.3K
Deferred tax expense (benefit)	$170.8K	-$406.8K	$203.5K
Unrealized loss from investment in securities	$7.7M	$819.4K	$5.5M
Investment (income)			-$4.0K
Share of results of associates	$427.7K	$204.6K
Loss on disposal of Long term investment		$101.4K
Property and equipment written off	$1.0K	$526
Accounts receivable	-$3.4M	$378.4K	-$1.2M
Insurance premium payables	$1.3M
Bank acceptance notes receivable	$376.0K	$949.5K	-$1.7M
Inventories	-$1.8M	$958.7K	$3.4M
Prepayment to suppliers	-$2.7M	-$65.5K	$492.9K
Other current assets	$12.6M	-$1.5M	$1.4M
Accounts payable	-$1.8M	$379.0K	-$1.6M
Contract liabilities	$2.7M	-$571.9K	$502.5K
Deferred government grants	$109.1K	-$96.4K	-$126.2K
Taxes payable	$577.5K	$101.8K	-$612.3K
Accrued expenses and other payables	-$11.0M	$359.2K	$539.8K
Lease liabilities	-$56.5K	-$100.6K	$4.3K
Net cash (used in) provided by operating activities	-$2.4M	$544.2K	$312.2K
Purchase of property and equipment	-$1.6M	-$240.1K	-$179.8K
Payment for construction in progress	-$498.9K	-$2.6M	-$1.7M
Purchase of intangible assets	-$121.4K	-$1.1M	-$1.9M
Cash received from disposal of Long term investment		$463.6K
Cash received from acquisition	$2.4M
Dividend received		$56.2K
Payment for short term investment	-$370.5K		-$1.0M
Proceeds from short term investment		$1.0M
Payments on long term investment		-$1.4M
Redemption from marketable securities		$4.8M
Purchase of non controlling interest			-$28.4K
Net cash (used in) provided by investing activities	-$162.9K	$983.4K	-$4.7M
Proceeds from bank loans	$2.2M		$496.2K
Repayment of bank loans	-$562.9K	-$491.7K	-$141.8K
Proceeds from (Repayment of) bank notes payable	$1.0M		-$1.5M
Non controlling interest contribution			$56.7K
Dividend paid			-$1.8M
Net cash provided by (used in) financing activities	$2.6M	-$491.7K	-$2.9M
Effect of exchange rate change on Cash, cash equivalents and restricted cash	-$80.4K	$1.3M	-$151.4K
Net increase (decrease) in Cash, cash equivalents and restricted cash	$3.2K	$2.3M	-$7.5M
Cash paid for interest	$35.3K	$4.3K	$3.7K
Cash paid for income taxes	$71.3K	$21.9K	$27.4K
Unpaid RMB 15,000,000$2,107,407) of 25% euqity investment (total considerarion of RMB 25,000,000) to Caihou Capital (Shenzhen) Group		$2.1M
Additional paid-in capital due to adjustments in previous years		$49.3K
Goodwill arising from the acquisition of the company by issuing shares 69,995,661 Class A ordinary shares per share of US$2.0	$350.8M
Right of Use Assets obtained in exchange for operating lease obligations	$374.6K

Compare BGM Group Ltd. with another company

Former names

Qilian International Holding GroupOct 22, 2024 to Oct 22, 2024³
Qilian International Holding Group LtdJun 17, 2019 to Oct 16, 2024³

Recent filings

Sep 24, 20266-K
Sep 8, 20266-K
Aug 28, 20266-K
Aug 11, 20266-K
Jul 30, 20266-K
Jul 28, 20266-K
Jul 21, 202620-F
Jul 13, 20266-K
Jun 17, 20266-K
Jun 9, 20266-K
May 18, 20266-K
May 14, 20263 OWNERSHIP DOCUMENT
May 14, 20263 OWNERSHIP DOCUMENT
May 14, 20263 OWNERSHIP DOCUMENT
May 14, 20263 OWNERSHIP DOCUMENT

Every filing from the last three years, summarized. The full record is on SEC EDGAR.¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBGM Group Ltd. filings on SEC EDGAR
2
SEC EDGARBGM Group Ltd. 10-K for fiscal 2025
3
SEC EDGARBGM Group Ltd. filings on SEC EDGAR
4
SEC EDGARBGM Group Ltd. 10-K for fiscal 2018
5
SEC EDGARBGM Group Ltd. 10-K for fiscal 2019
6
SEC EDGARBGM Group Ltd. 10-K for fiscal 2020
7
SEC EDGARBGM Group Ltd. 10-K for fiscal 2021
8
SEC EDGARBGM Group Ltd. 10-K for fiscal 2022